Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0011570 (depression)
 172,036 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Unrecognized, untreated and undertreated depressive disorders incur inordinate human and economic costs, despite the availability of an exclusive array of clinical interventions. The aim of this study was to identify cases of masked depression in primary health care, employing a two-stage design. In the first stage, involving a study of 442 patients, the prevalence of recognized depression was 1.8%. In the second step, 62 patients from stage 1 were investigated further because of their high score on somatization tendency. In total, 41 of the 62 patients were found to have a mood disorder according to DSM-III-R, i.e. a major depressive disorder or dysthymia. Two patients were found to have already had a diagnosis of major depression assigned to them in stage 1, but they were joined by 13 more patients. A further 26 patients were found to be suffering from dysthymia, nine had adjustment disorders with depressed mood, and 12 patients showed no signs of depressed mood. For the group suffering from a current episode of major depression or dysthymia, the prevalence rate increased to 11.7% in the initial total population after stage 2. The diagnostic category with the highest rate of depressed patients was 'musculoskeletal diseases'. Patients with masked depression had higher scores for alexithymia and psychasthenia than depressed patients who were directly diagnosed.
 ...
PMID:Depressive disorders among somatizing patients in primary health care. 976 4

This study examined depression, anxiety, coping styles, optimism, selected personality characteristics, and perception of family environment among candidates for liver transplantation (OLTX); the goal was to measure and empirically describe psychosocial factors reported to impact on the experience and outcome of transplantation. Subjects were 73 US military veterans being considered for OLTX at the VAMC-Pittsburgh (UD) from 1994 to 1996. Psychological evaluation consisted of chart review, consultation with the transplant team, clinical interview and administration of published, standardized, and readily available psychological tests. Candidates displayed above normal levels of situational anxiety and depression, mainly adaptive coping styles, mild optimism, and positive family environments. Factor analysis of the data identified two dimensions of psychological distress, five coping styles, and three types of family environment. The composite MMPI-2 profile for the sample shows marked elevations of the neurotic triad and moderate elevations of psychasthenia and schizophrenia scales. Psychological distress, psychopathology, coping styles, optimism, and perceptions of family environment correlate with each other in the directions suggested by the literature. These findings support previous research with empirical data; results encourage the development of consistent psychological protocols and procedures to evaluate and treat organ transplant candidates.
 ...
PMID:Psychological characteristics of candidates for liver transplantation. 978 51

Psychological testing of 63 normal subjects and 84 patients with keratocone was carried out separately for men and women aged 18-64 years using 11 scores of a brief multifactorial questionnaire for personality examination (BMQP). Comparison of averaged profiles of examined men and women with keratocone showed features of sensitive and psychasthenic personalities. According to BMQP scores, the population of men with keratocone is characterized by increased levels of psychasthenia and schizophrenia, whereas women develop depression, psychasthenia, and schizophrenia.
 ...
PMID:[Results of psychological testing of patients with keratoconus]. 995 88

The psychological needs derived from the Adjective Check List (ACL; Gough & Heilbrun, 1983b) that are associated with MMPI-2 scales were studied among 198 nonclinical participants. Both the Depression (D) and Psychasthenia (Pt) scales were negatively correlated with needs for achievement and dominance and positively correlated with needs for abasement and succorance (dependence). The Schizophrenia (Sc) scale was negatively associated with need for affiliation and positively associated with need for abasement. The Social Introversion (Si) scale was associated negatively with needs for achievement, dominance, affiliation, heterosexuality, exhibition, and autonomy and associated positively with needs for succorance, abasement, and deference, reflecting good construct validity for Scale Si. MMPI-2 Masculinity-Femininity (Mf) did not correlate with the ACL Masculinity and Femininity scales, suggesting poor concurrent validity for Mf.
 ...
PMID:Psychological needs associated with MMPI-2 scales in a nonclinical sample. 1090 May 70

When abnormal psychologic/psychiatric symptom data are obtained on personality tests or psychiatric interviews administered to patients who report symptoms of Multiple Chemical Sensitivities Syndrome, investigators typically attribute these to either psychiatric traits or to psychogenic origins of illness. The primary purpose of these studies was the evaluation of the plausibility of nonpsychiatric explanations of psychologic/psychiatric symptom data. In Study 1, patients with Multiple Chemical Sensitivities Syndrome used the Minnesota Multiphasic Personality Inventory 2 (MMPI-2) to describe which items had changed after they developed the condition. In Study 2, three diverse groups of professionals predicted which items on the MMPI-2 might change after a mentally healthy person developed the Syndrome or a condition resembling it. In Study 3, a second sample of Multiple Chemical Sensitivities Syndrome patients completed the MMPI-2 and other questionnaires by mail, which allowed the authors to ascertain whether these patients showed more or different psychopathology than was described by patients and hypothesized by professionals. Data from Study 1 patient informants indicated that developing the syndrome might result in a psychopathological MMPI-2 profile, characterized by abnormal Hypochondriasis and Hysteria scale scores. Professionals in Study 2 showed a consensus about hypothesized MMPI-2 changes following the development of the syndrome. These changes likely elevated the Hypochondriasis, Hysteria, Psychasthenia, Depression, and Schizophrenia scale scores. In Study 3, the patients taking the MMPI-2 showed elevations on the Hypochondriasis, Hysteria, Depression (women only), and Schizophrenia scales. Abnormal scores were associated closely with greater severity of illness and greater adjustment to illness. The strategy of administering psychometric tests to ill populations for the purposes of evaluating psychiatric illness or traits, and/or psychogenic origins of illness was shown to be potentially misleading.
 ...
PMID:Psychiatric inferences from data on psychologic/psychiatric symptoms in multiple chemical sensitivities syndrome. 1090 99

The investigation of personality traits of migraineurs with the Minnesota Multiphasic Personality Inventory (MMPI) is important research, but so far has led to diverse conclusions. This study aimed to investigate the influences of treatment intervention on the personality of migraineurs. Twenty-three Chinese patients (5 men, 18 women) with migraine (2 with aura, 21 without aura) were given the Chinese edition of the MMPI, before and after treatment, and were compared with 30 nonheadache healthy control subjects (6 men, 24 women). Statistical analyses were made among the three groups. The results revealed that patients in the pretreatment group with migraine had significantly higher scores on subtests of neuroticism (hypochondriasis, depression, hysteria) and schizophrenia. After treatment, the scores on subtests of hysteria, psychasthenia, and schizophrenia were remarkably lower (P < .05); the MMPI profile of the posttreatment group was within the reference range, but the scores of the neurotic scales were still higher than those of the healthy control group (P < .01). These results suggest that after treatment, disturbances in thinking, sentiment, and behavior were eliminated, and anxiety symptoms remarkably reduced, but some "migraine personality" characteristics remained and could influence the long-term results of treatment to some extent. It is suggested that management of migraine should include psychological intervention.
 ...
PMID:MMPI changes associated with therapeutic intervention: a migraine control study. 1127 75

The present article examines the utility of the MMPI-2 for the subtyping of social phobia (SP). Cluster analysis was conducted on the MMPI-2 profiles of 109 patients with SP. Clusters were compared on demographic and clinical variables prior to treatment, as well as following completion of cognitive-behavioral group therapy (CBGT). Three distinct clusters emerged. The first is characterized by an absence of significant scale elevations and appears to be consistent with the reported "circumscribed" subtype of SP. It is associated with a significantly later age at onset of SP, a higher proportion of married individuals, and lower scores on pretreatment clinical variables. Significant elevations on Scales 2 (Depression) and 7 (Psychasthenia) and moderately high scores on pretreatment clinical variables characterize the second cluster. The third cluster is characterized by significantly high elevations on Scales 8, 7, and 2, and the highest scores on pretreatment clinical variables. Patients from all three groups improved significantly following a course of CBGT.
 ...
PMID:Social phobia subtyping with the MMPI-2. 1174 91

Personality, mental distress, and risk perception were assessed in (a) cases of multiple chemical sensitivity (MCS; n = 17), (b) chemically intolerant toxic encephalopathy cases (TE), type 2A (n = 31) and 2B (n = 26), and (c) healthy referents (n = 200). MCS cases showed elevated mental distress scores on the Depression, Interpersonal Sensitivity, Global Severity Index, and Somatization scales in the Symptom Checklist 90 (SCL-90). In the Karolinska Scales of Personality (KSP) the MCS group showed an elevation only on the Psychasthenia scale. Both TE groups showed elevations across the KSP anxiety scales Muscular Tension, Psychasthenia, and Somatic Anxiety. TE type 2B subjects also showed elevations on the Irritability and Indirect Aggression scales. However, neither MCS nor TE groups showed deviating personality characteristics in the Meta Contrast Technique test. Similarly, none of the groups deviated from referents in a risk perception inventory.
 ...
PMID:Personality, mental distress, and risk perception in subjects with multiple chemical sensitivity and toxic encephalopathy. 1200 55

Using the Karolinska Scales of Personality (KSP), we investigated the effect of the selective serotonin reuptake inhibitor citalopram on personality traits and the relationship between personality traits and peripheral indexes for central serotonergic function in patients with panic disorder at baseline and after 6 months of treatment. The degree of anxiety and depression was assessed using the Beck Anxiety Inventory, the Beck Depression Inventory, the Clinical Anxiety Scale, and the Montgomery Asberg Depression Rating Scale. A reduction in anxiety and depression scores of 75% was observed after treatment in two thirds of the patients. Mean changes of 12% in the direction of normalization were observed in all KSP anxiety-related items (Somatic Anxiety, Muscular Tension, Psychic Anxiety, and Psychasthenia), the aggression and hostility related items (Inhibition of Aggression, Irritability, and Guilt) and the item of Socialisation. A positive correlation was found between Vmax for the platelet [14C]-serotonin uptake and Inhibition of Aggression before treatment, and a negative correlation was found between the affinity of serotonin uptake and Inhibition of Aggression after treatment. Negative childhood experiences influenced enhanced scores on some KSP items but not the serotonergic function. In panic patients treated with citalopram, effects were seen on personality traits, confirming an association between serotonergic activity and aggression.
 ...
PMID:Effect of citalopram treatment on relationship between platelet serotonin functions and the Karolinska scales of personality in panic patients. 1217 40

Individuals at-risk for Huntington disease (HD), both HD gene carriers and nongene carriers, were recruited to determine whether psychological changes are detectable among clinically presymptomatic individuals who carry the HD allele. Each participant underwent genotyping to determine HD gene carrier status and a clinical assessment that included a quantified neurological examination and an abbreviated Minnesota Multiphasic Personality Inventory (MMPI): the Hypochondriasis, Depression, Psychasthenia, Neuroticism, Cynical Hostility, and Irritability Scales and the Harris Subscales of Depression. The results of the MMPI were evaluated for differences between nongene carriers (NGC) (n = 363), presymptomatic gene carriers (PSGC) (n = 149), and those with manifest HD (MHD) (n = 26). The overall multiple analysis of variance was not significant, indicating that there was no overall difference among the three groups. However, when subscales of the MMPI were examined individually, participants with manifest HD scored higher on the Psychasthenia scale (MHD vs. PSGC, P = 0.005; MHD vs. NGC, P = 0.03) and the Harris Depression subscale, Brooding (MHD vs. PSGC, P=0.0005; MHD vs. NGC, P = 0.003). No significant correlation was found between the number of trinucleotide repeats on the disease-producing allele and any of the MMPI scales for the gene carriers, MHD or PSGC. These results verify the presence of psychological symptoms in the early phases of MHD but not in PSGC. Thus, further study of the behavioral and mood symptoms thought to accompany HD using measures designed specifically to detect depressive symptoms and changes in behavior specific to HD is warranted to delineate the timing of onset of the psychological symptoms.
 ...
PMID:Evaluation of psychological symptoms among presymptomatic HD gene carriers as measured by selected MMPI scales. 1239 6


<< Previous 1 2 3 4 5 6 7 8 Next >>